Walter Ferlin

4.5k total citations · 1 hit paper
65 papers, 3.2k citations indexed

About

Walter Ferlin is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Walter Ferlin has authored 65 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 20 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Walter Ferlin's work include Immune Cell Function and Interaction (23 papers), Phagocytosis and Immune Regulation (13 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Walter Ferlin is often cited by papers focused on Immune Cell Function and Interaction (23 papers), Phagocytosis and Immune Regulation (13 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Walter Ferlin collaborates with scholars based in Switzerland, United States and Italy. Walter Ferlin's co-authors include David A. Ferrick, Thera Mulvania, Mark D. Schrenzel, Marie Kosco‐Vilbois, François Guilhot, Rami Lissilaa, Stefan Rose‐John, Brendan J. Jenkins, Cristina de Min and Maureen Howard and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Walter Ferlin

63 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

1995 579 citations David A. Ferrick, Mark D. Schrenzel et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walter Ferlin Switzerland	30	2.0k	707	579	465	339	65	3.2k
Venetia Bigley United Kingdom	21	2.2k 1.1×	631 0.9×	677 1.2×	279 0.6×	314 0.9×	39	3.2k
James Verbsky United States	28	2.9k 1.4×	501 0.7×	628 1.1×	630 1.4×	425 1.3×	81	3.8k
Timothy S. Olson United States	28	1.9k 0.9×	671 0.9×	976 1.7×	824 1.8×	389 1.1×	98	3.9k
Kyriaki Dunussi‐Joannopoulos United States	17	2.9k 1.4×	794 1.1×	496 0.9×	261 0.6×	305 0.9×	29	3.7k
Taku Kouro Japan	24	2.0k 1.0×	493 0.7×	575 1.0×	485 1.0×	197 0.6×	51	2.9k
Luisa Imberti Italy	32	2.2k 1.1×	745 1.1×	596 1.0×	370 0.8×	642 1.9×	156	3.8k
Junliang Pan United States	27	2.8k 1.4×	1.3k 1.8×	839 1.4×	316 0.7×	361 1.1×	38	4.6k
Renxi Wang China	33	2.2k 1.1×	693 1.0×	776 1.3×	161 0.3×	311 0.9×	157	3.6k
Harumichi Ishigame Japan	18	3.4k 1.7×	739 1.0×	768 1.3×	196 0.4×	399 1.2×	28	4.7k
Robert N. Barker United Kingdom	31	1.6k 0.8×	613 0.9×	573 1.0×	714 1.5×	418 1.2×	95	3.3k

Countries citing papers authored by Walter Ferlin

Since Specialization

Citations

This map shows the geographic impact of Walter Ferlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Ferlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Ferlin more than expected).

Fields of papers citing papers by Walter Ferlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Ferlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Ferlin. The network helps show where Walter Ferlin may publish in the future.

Co-authorship network of co-authors of Walter Ferlin

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Ferlin. A scholar is included among the top collaborators of Walter Ferlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Ferlin. Walter Ferlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chauchet, Xavier, Laura Cons, Laurence Chatel, et al.. (2022). CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model. Experimental Hematology and Oncology. 11(1). 26–26. 20 indexed citations

Merli, Pietro, Ignazio Caruana, Rita De Vito, et al.. (2019). Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 104(11). 2314–2323. 49 indexed citations

Pasquin, Sarah, Bouchra Meddah, Walter Ferlin, et al.. (2017). Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling. Journal of Biological Chemistry. 292(16). 6644–6656. 41 indexed citations

Prencipe, Giusi, Ivan Caiello, Antonia Pascarella, et al.. (2017). Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome. Journal of Allergy and Clinical Immunology. 141(4). 1439–1449. 86 indexed citations

Bonvin, Pauline, Franck Gueneau, Vanessa Buatois, et al.. (2017). Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine. Journal of Biological Chemistry. 292(10). 4185–4197. 15 indexed citations

McLeod, Louise, Sultan Alhayyani, Alistair Miller, et al.. (2016). IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis. Cancer Research. 76(4). 866–876. 95 indexed citations

Miller, Alistair, Louise McLeod, Sultan Alhayyani, et al.. (2016). Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma. Oncogene. 36(21). 3059–3066. 74 indexed citations

Buatois, Vanessa, Laurence Chatel, Laura Cons, et al.. (2016). Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis. Translational research. 180. 37–52.e2. 46 indexed citations

Deehan, Maureen R., et al.. (2016). Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance. Journal of Immunology Research. 2016. 1–15. 31 indexed citations

10.

Lima, Cristiano Xavier, Danielle G. Souza, Flávio A. Amaral, et al.. (2015). Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis. PLoS ONE. 10(7). e0132336–e0132336. 48 indexed citations

11.

Corbera‐Bellalta, Marc, Ester Planas‐Rigol, Ester Lozano, et al.. (2015). Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis. Annals of the Rheumatic Diseases. 75(6). 1177–1186. 95 indexed citations

12.

Tormo, Aurélie, Marie-Claude Letellier, Rami Lissilaa, et al.. (2012). The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities. Cytokine. 60(3). 653–660. 12 indexed citations

13.

Elson, Greg, Theresa H. Page, Vanessa Buatois, et al.. (2011). NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis. Oxford University Research Archive (ORA) (University of Oxford). 63. 5 indexed citations

14.

Montecucco, Fabrizio, Vincent Braunersreuther, Sébastien Lenglet, et al.. (2011). CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. European Heart Journal. 33(15). 1964–1974. 114 indexed citations

15.

Tormo, Aurélie, Dorothée Duluc, Rami Lissilaa, et al.. (2009). The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling. The Journal of Immunology. 183(12). 7692–7702. 111 indexed citations

16.

Daubeuf, Bruno, John C. Mathison, Stéphanie Hugues, et al.. (2007). TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock. The Journal of Immunology. 179(9). 6107–6114. 99 indexed citations

17.

Masteller, Emma L., Walter Ferlin, Valeria Judkowski, et al.. (2003). Peptide-MHC Class II Dimers as Therapeutics to Modulate Antigen-Specific T Cell Responses in Autoimmune Diabetes. The Journal of Immunology. 171(10). 5587–5595. 68 indexed citations

18.

Ferlin, Walter, Nicolas Glaichenhaus, & Evelyne Mougneau. (2000). Present difficulties and future promise of MHC multimers in autoimmune exploration. Current Opinion in Immunology. 12(6). 670–675. 19 indexed citations

19.

Ferlin, Walter, Eva Severinson, Lena Ström, et al.. (1996). CD40 signaling induces interleukin‐4‐independent IgE switching in vivo. European Journal of Immunology. 26(12). 2911–2915. 27 indexed citations

20.

Ferrick, David A., et al.. (1995). Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature. 373(6511). 255–257. 579 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact